Search results for "Prostate Cancer"
Be on alert for blood cancer precursors
Joseph R. Mikhael, MD, FACP, reviewed practical approaches to two premalignant conditions, monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL).
https://immattersacp.org/archives/2023/07/be-on-alert-for-blood-cancer-precursors.htm
1 Jul 2023
Make screening for prostate cancer an individual choice, USPSTF says
Prostate-specific antigen-based screening programs in men ages 55 to 69 years may prevent approximately 1.3 deaths from prostate cancer over approximately 13 years per 1,000 men screened, as well as approximately three cases of metastatic prostate cancer per 1,000 men screened, the U.S. Preventive Services Task Force (USPSTF) found.
https://immattersacp.org/weekly/archives/2018/05/15/1.htm
15 May 2018
Patients and priorities in prostate cancer care
Prostate cancer requires men to work through a multitude of treatment options, and if the patient ends up settling on active surveillance, then the internist's role is even more important moving forward.
https://immattersacp.org/archives/2017/11/patients-and-priorities-in-prostate-cancer-care.htm
1 Nov 2017
Little difference found among prostate cancer treatments regarding clinical results, patient-reported outcomes
More men in the active-monitoring group developed metastases than in the surgery or radiotherapy groups, and there were higher rates of disease progression in the active-monitoring group than in the surgery or radiotherapy groups.
https://immattersacp.org/weekly/archives/2016/09/20/2.htm
20 Sep 2016
Sorting through the science of PSA screening
An expert clears up issues surrounding prostate cancer screening recommendations at Internal Medicine Meeting 2022.
https://immattersacp.org/archives/2022/07/sorting-through-the-science-of-psa-screening.htm
1 Jul 2022
Surgery performs better than radiotherapy for non-metastatic prostate cancer
Surgery was associated with better survival than radiotherapy in men with non-metastatic prostate cancer, according to a large observational study with follow-up as long as 15 years.
https://immattersacp.org/weekly/archives/2014/03/11/5.htm
11 Mar 2014
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
Comorbid illnesses still more likely to kill prostate cancer survivors
Veterans Affairs solicits applications for centers of excellence
https://immattersacp.org/weekly/archives/2010/08/31/6.htm
31 Aug 2010
More patients undergoing active surveillance for lower-risk prostate cancers
Use of active surveillance or watchful waiting for prostate cancer rose from 2010 to 2018, although uptake was lower in men with multiple positive biopsy cores and those who were Asian/Pacific Islander and Hispanic, had a lower income, or lived in a rural area.
https://immattersacp.org/weekly/archives/2023/04/11/4.htm
11 Apr 2023
OTC birth control pill, naloxone gain approval
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023